Free Trial

Privia Health Group (PRVA) Stock Price, News & Analysis

Privia Health Group logo
$21.35 -0.76 (-3.44%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$22.02 +0.67 (+3.14%)
As of 07/7/2025 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Privia Health Group Stock (NASDAQ:PRVA)

Key Stats

Today's Range
$21.32
$22.17
50-Day Range
$21.35
$25.07
52-Week Range
$16.47
$26.09
Volume
979,124 shs
Average Volume
761,192 shs
Market Capitalization
$2.60 billion
P/E Ratio
177.93
Dividend Yield
N/A
Price Target
$27.77
Consensus Rating
Buy

Company Overview

Privia Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
87th Percentile Overall Score

PRVA MarketRank™: 

Privia Health Group scored higher than 87% of companies evaluated by MarketBeat, and ranked 132nd out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Privia Health Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Privia Health Group has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Privia Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for Privia Health Group are expected to grow by 92.86% in the coming year, from $0.14 to $0.27 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Privia Health Group is 177.93, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.68.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Privia Health Group is 177.93, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.19.

  • Price to Earnings Growth Ratio

    Privia Health Group has a PEG Ratio of 3.54. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Privia Health Group has a P/B Ratio of 3.75. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Privia Health Group's valuation and earnings.
  • Percentage of Shares Shorted

    3.18% of the float of Privia Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Privia Health Group has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

  • Dividend Yield

    Privia Health Group does not currently pay a dividend.

  • Dividend Growth

    Privia Health Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.18% of the float of Privia Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Privia Health Group has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

  • News Sentiment

    Privia Health Group has a news sentiment score of 1.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Privia Health Group this week, compared to 4 articles on an average week.
  • Search Interest

    4 people have searched for PRVA on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,100,368.00 in company stock.

  • Percentage Held by Insiders

    10.70% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    94.48% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Privia Health Group's insider trading history.
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

PRVA Stock News Headlines

Analysts Set Privia Health Group, Inc. (NASDAQ:PRVA) PT at $27.77
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
PRVA Privia Health Group, Inc. - Seeking Alpha
Privia Health Group Inc (PRVA) - Investing.com
See More Headlines

PRVA Stock Analysis - Frequently Asked Questions

Privia Health Group's stock was trading at $19.55 at the start of the year. Since then, PRVA shares have increased by 9.2% and is now trading at $21.35.

Privia Health Group, Inc. (NASDAQ:PRVA) issued its quarterly earnings results on Thursday, August, 8th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.05 by $0.02. Privia Health Group's quarterly revenue was up 2.2% compared to the same quarter last year.
Read the conference call transcript
.

Privia Health Group (PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Privia Health Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
8/08/2024
Today
7/07/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Healthcare
Current Symbol
NASDAQ:PRVA
Fax
N/A
Employees
1,140
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$27.77
High Stock Price Target
$40.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+30.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
13 Analysts

Profitability

Trailing P/E Ratio
177.93
Forward P/E Ratio
152.50
P/E Growth
3.54
Net Income
$14.39 million
Pretax Margin
1.79%

Debt

Sales & Book Value

Annual Sales
$1.74 billion
Cash Flow
$0.17 per share
Price / Cash Flow
122.53
Book Value
$5.70 per share
Price / Book
3.75

Miscellaneous

Free Float
108,875,000
Market Cap
$2.60 billion
Optionable
Optionable
Beta
0.82
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:PRVA) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners